Results 1 to 10 of about 275 (74)

Vliyanie ozhireniya na tolshchinu kompleksa intima ? media u zhenshchin v postmenopauze

Сахарный диабет, 2004
Цель. Оценка влияния ожирения и ИМТ на морфологические изменения сосудистой стенки крупных (магистральных) сосудов, как ОСА, так и БА, у женщин в постменопаузе, а также в установлении связи между изменениями сосудистой стенки и наличием метаболического ...
A V Starodubova, G I Storozhakov, O A Kislyak, O N Tsareva   +3 more
doaj   +1 more source

Features of bone tissue reconstruction in periand postmenopausal women with type 1 diabetes mellitus

Сибирский научный медицинский журнал, 2019
Aim of the study - to assess the impact of changes in women’s bodies with diabetes mellitus type 1 on the state of bone mineral density and its metabolic rate, to determine the tendency of changes in serum markers of bone remodeling and bone mineral ...
S. S. Safarova
doaj   +1 more source

Experience of managing menopausal symptoms and quality of sleep with melatonin

Медицинский совет, 2016
Melatonin is one of the most underestimated agents of the endocrine system. While remaining undeservedly in the shadow of clinical science, it adjusts the body to the systemic changes of the external and internal environment. The periods of perimenopause
E. V. Bryukhina, E. N. Usoltseva, D. I. Burchakov   +2 more
doaj   +1 more source

Zamestitel'naya gormonal'naya terapiya i techenie distal'noy diabeticheskoy polineyropatii u zhenshchin v postmenopauze

Сахарный диабет, 2007
Цель. Оценка влияния препаратов эстрогенов в сочетании с прогестагенами на течение диабетической полинейропатии у женщин в постменопаузе. Материалы и методы.
T A Zelenina, N V Vorokhobina, O F Malygina, E A Volkova   +3 more
doaj   +1 more source

Management of postmenopausal women: what the clinician can rely on?

Медицинский совет, 2014
This review discusses the reasons for the low use of menopausal hormone therapy (MHT) in postmenopausal women, results of recent evidence-based studies showing favorable benefit/risk profile associated with MHT in women aged 50--59 years and/or menopause
S. V. Yureneva, L. M. Ilyin
doaj   +1 more source

CORRECTION OF PSYCHO-AUTONOMIC DISORDERS IN WOMEN WITH ARTERIAL HYPERTENSION DURING POSTMENOPAUSAL PERIOD

Рациональная фармакотерапия в кардиологии, 2016
Aim. To assess an efficacy of adaptol in women with arterial hypertension (HT) during postmenopausal period.Material and methods. Postmenopausal women (n=60) with HT were examined.
G. G. Semenkova, E. E. Matvienko
doaj   +1 more source

SNIZhENIE MINERAL'NOY PLOTNOSTI KOSTNOY TKANI -DOPOLNITEL'NYY KRITERIY STRATIFIKATsII SERDEChNOSOSUDISTOGO RISKA U ZhENShchIN POSTMENOPAUZAL'NOGO PERIODA S ARTERIAL'NOY GIPERTONIEY

Остеопороз и остеопатии, 2010
Изучены особенности сердечно-сосудистого ремоделирования у нормотензивных пациенток и женщин с АГ и пост- менопаузальным остеопеническим синдромом (ОП). Обследовано 207 женщин постменопаузального периода: 62 - с АГ и ОП; 43 - с АГ и нормальной МПКТ; 52 -
N Yu Khozyainova, V M Tsareva, Yu V Kurbasova, T V Bruk, N V Romanchenko, O V Petrushchenkova   +5 more
doaj   +1 more source

Lipid peroxidation and antioxidant system in menopausal women with insomnia

Acta Biomedica Scientifica, 2016
According to the current data, most menopausal women have reduced life quality and one of the main criteria is sleep quality. It is well known, that sleep loss may cause oxidative stress.
N. V. Semyonova
doaj   +1 more source

«ZDOROV'E KOSTI I SAKhARNYY DIABET» ( PEREVOD S ANGL.)

Остеопороз и остеопатии, 2011
«Сахарный диабет (СД) 1 типа определенно ассоциируется со снижением костной массы и подавлением процессов формирования кости. Предполагается, что более чем у 50% пациентов с СД 1 типа костная масса снижена, по сравнению со здоровыми, парными по возрасту ...
MARIA LUISA BRANDI
doaj   +1 more source

RESULTS AND EFFECTIVENESS PREDICTORS OF ALENDRONATETHERAPY IN POSTMENOPAUSAL PATIENTS WITH PRIMARYHYPERPARATHYROIDISM

Остеопороз и остеопатии, 2010
Primary hyperparathyroidism (PHPT) is a common disorder often associated with reduced bone mineral density (BMD) and osteoporosis. The main goal in treating patients who refuse surgery is the correction of bone complications.
I I Dedov, A V Belyaeva, L Ya Rozhinskaya, N G Mokrysheva, S S Mirnaya, G S Kolesnikova, A V Il'in, N I Sazonova, T O Chernova, A M Artemova, I I Dedov, A. V. Belyaeva, L. Y. Rozhinskaya, N. G. Mokrysheva, S. S. Mirnaya, G. S. Kolesnikova, A. V. Ilyin, N. I. Sazonova, T. O. Chernova, A. M. Artemova   +19 more
doaj   +1 more source